Get faster funding for your research
Bio makes scientific research easier to fund and coordinate. Raise directly from a global community of your supporters and build a movement around your science. Access more efficient and transparent markets for the next generation of breakthrough science.
Learn DeSci fast. Get the Playbook here.
- Treasuries raised
$0+$0+ - Funded research
$0+$0+ - Ecosystem trading
$0+$0+ - Community Members
00
THE BIO LAUNCH PIPELINE
Your path to DeSci success
1
Prepare your launch
Set up your wallet, tokenomics, and legal docs in the Bio Buildspace, with your team guided step by step.
2
Launch on Bio Protocol
Go live on Bio’s Launchpad and get promoted across our socials.
3
Reach milestones and access funding
Unlock funding transparently as you hit clearly defined milestones.
4
Build for science and community
Report monthly on scientific impact, commercialization, financial health, and governance, and stay on track.
LAUNCHED ON BIO
Projects that went from idea to protocol
Peptai
PeptAI is an autonomous AI agent that discovers new peptide drug candidates. It designs peptides computationally, then pushes them through an 8-gate validation pipeline. Every result is published on-chain (blockchain) so anyone can verify the science. Once a candidate passes validation, it's sent to the wet-lab for synthesis and binding assays. PeptAI is receptor agnostic, however first programmes target GLP1R, KISS1R, OX2R and several other GPCRs.
SpineDAO
Revolutionizing spine care for millions worldwide. By leveraging blockchain, AI, and collaborative decentralized science, SpineDAO creates an open platform for optimizing surgical decisions, improving patient outcomes, and democratizing access to spine knowledge.
Cerebrum DAO
Cerebrum DAO is building the world’s largest engaged community focused on enabling scientific breakthroughs that prevent the onset of neurodegeneration and extend our healthy brain years.
VitaStem by Aubrai
VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline…
Neuron-Gale
The galectin-3 Inhibitors project tests a small molecule under development for peripheral indications for treating neuroinflammation in an Alzheimer’s mouse model. By blocking galectin-3, it aims to reduce brain inflammation, with potential in other neurodegenerative diseases. Galectin-3 is involved in neuroinflammation, thereby the inhibitor has a potential to be used in multiple neurodegenerative diseases.
eDMT Commons
eDMT Commons enables shared governance over multiple R&D efforts into how the brain regulates its own DMT. This Commons IPT coordinates funding across diverse approaches, accelerating discovery while ensuring knowledge remains community-governed. Token holders benefit from any project funded by or joining the consortium. The flagship project seeks to uncover how endogenous DMT is regulated in the mammalian brain by isolating and sequencing enzymes that act as an “off switch” for DMT…
JOIN THE ECOSYSTEM
What you can expect
Bio’s Distribution and Reach
Connect with a broad audience of supporters, contributors, and potential collaborators by accessing Bio’s established distribution and reach in the DeSci and Web3 space.
Web3 Operational Expertise
Benefit from Bio’s operational expertise across DeSci, Web3 and Governance via the Bio Docs and dedicated support channels. We want you and your team to succeed as much as you do.
Agentic Team Assistants
Speed up and improve your operational workflows with bespoke agentic team assistants developed and maintained by Bio. Milestone reporting, automated research pipelines, and more.
Reporting & BI Tooling
Iterate with intent based on insights from Bio’s data dashboards and reporting. Work towards research and funding milestones and grow your impact.
Legal and Safety Frameworks
Be prepared for when things go off-track, with processes for leadership changes and community accountability. Bio provides legal frameworks which are hard to come by for smaller teams operating on their own.
Bio Protocol
How DeSci funds science
A new model that rewards scientific progress
Researchers shouldn’t have to chase grants to keep their work alive.
Bio turns your research into a self-sustaining cycle: strong science attracts early funding, progress creates IP, commercialization returns proceeds to your project, so each round unlocks greater resources for the next. That keeps your lab funded and lets you stay head down, doing the science only you can do.
Continuous funding that fuels discoveries
As your project gains traction, that momentum opens the door to new funding—no grant forms, no milestone paperwork. Early backers participate in the upside, and each milestone primes the next tranche, creating a transparent, adaptive loop that helps fund your project’s next breakthrough while you stay focused on the science.
Bio's Milestone-Based funding approach
COMMUNITY
From the scientists who build with Bio
This is the breakout moment for DeSci and there is no better incubator and launchpad for Curetopia than BIO.
Bio gave our lab a path from early research to community-backed funding without losing scientific focus. The milestone model keeps us accountable and moving.
We needed distribution and operational support as much as capital. Bio’s network and tooling turned a promising idea into a live protocol.
Raising through Bio meant we could stay heads-down on the science while the community carried the launch. That combination is hard to find elsewhere.
Get faster funding with Bio
Go from curiosity to capital to reproducible data with a full-stack solution for decentralized biotech, covering everything from fundraising to IP management.